General Information of Disease (ID: DISYCWUG)

Disease Name Spinal muscular atrophy, type 1
Synonyms
spinal muscular atrophy, type I; proximal spinal muscular atrophy, type 1; SMA, infantile acute form; muscular atrophy, infantile; proximal spinal muscular atrophy type 1; spinal muscular atrophy 1; infantile spinal muscular atrophy; spinal muscular atrophies of childhood; infantile muscular atrophy; progressive muscular atrophy of infancy; SMA1; HMN (hereditary motor neuropathy) proximal type I; SMA type 1; severe infantile spinal muscular atrophy; Werdnig Hoffmann disease; SMNI; SMA type I; Werdnig-Hoffmann disease; survival motor neuron spinal muscular atrophy; Werdnig-Hoffmann Disease; Werdnig-Hoffman disease; spinal muscular atrophy-1; hereditary motor neuropathy proximal type I; SMA-I
Definition
A severe infantile form of proximal spinal muscular atrophy characterized by severe and progressive muscle weakness and hypotonia resulting from the degeneration and loss of the lower motor neurons in the spinal cord and the brain stem nuclei.
Disease Hierarchy
DIS0R70E: Proximal spinal muscular atrophy
DISYCWUG: Spinal muscular atrophy, type 1
Disease Identifiers
MONDO ID
MONDO_0009669
MESH ID
D014897
UMLS CUI
C0043116
OMIM ID
253300
MedGen ID
21913
Orphanet ID
83330
SNOMED CT ID
64383006

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 3 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
AVPR2 TTK8R02 Strong Biomarker [1]
UBA1 TTXHWA7 Strong Genetic Variation [2]
SMN1 TT8QL6X Definitive Autosomal recessive [3]
------------------------------------------------------------------------------------
This Disease Is Related to 10 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACTA1 OTOVGLPG Strong Altered Expression [4]
COIL OTP4I4DL Strong Biomarker [5]
GTF2H2 OTK72L9I Strong Altered Expression [6]
GTF2H3 OT87W5QJ Strong Altered Expression [6]
GTF2H5 OTRL219S Strong Altered Expression [6]
IGFALS OTTWCZYM Strong Biomarker [7]
IGHMBP2 OTAZFPF5 Strong Biomarker [8]
NAIP OTLA925F Strong GermlineModifyingMutation [9]
TBCD OTS4JKNQ Strong Biomarker [10]
SMN1 OT54RLO1 Definitive Autosomal recessive [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 DOT(s)

References

1 Nephrogenic diabetes insipidus and Werdnig-Hoffmann disease in a child: an unusual association.J Med Genet. 1978 Jun;15(3):219-21. doi: 10.1136/jmg.15.3.219.
2 Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. Am J Hum Genet. 2008 Jan;82(1):188-93. doi: 10.1016/j.ajhg.2007.09.009.
3 Classification of Genes: Standardized Clinical Validity Assessment of Gene-Disease Associations Aids Diagnostic Exome Analysis and Reclassifications. Hum Mutat. 2017 May;38(5):600-608. doi: 10.1002/humu.23183. Epub 2017 Feb 13.
4 Epidemiological data on Werdnig-Hoffmann disease in Germany (West-Thringen).Hum Genet. 1993 Apr;91(3):295-7. doi: 10.1007/BF00218278.
5 Reorganization of Cajal bodies and nucleolar targeting of coilin in motor neurons of type I spinal muscular atrophy.Histochem Cell Biol. 2012 May;137(5):657-67. doi: 10.1007/s00418-012-0921-8. Epub 2012 Feb 1.
6 The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease.Am J Hum Genet. 1997 Jan;60(1):72-9.
7 Involvement of the Onuf nucleus in Werdnig-Hoffmann disease.Neurology. 1982 Aug;32(8):880-4. doi: 10.1212/wnl.32.8.880.
8 An atypical phenotype of a patient with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD 1).Eur J Med Genet. 2018 Oct;61(10):602-606. doi: 10.1016/j.ejmg.2018.04.001. Epub 2018 Apr 11.
9 Molecular genetics of spinal muscular atrophy: contribution of the NAIP gene to clinical severity.Kobe J Med Sci. 2002 Apr;48(1-2):25-31.
10 TBCD may be a causal gene in progressive neurodegenerative encephalopathy with atypical infantile spinal muscular atrophy.J Hum Genet. 2017 Apr;62(4):473-480. doi: 10.1038/jhg.2016.149. Epub 2016 Dec 8.